102. The palm is ~0.5% TBSA - Insurance companies denying coverage - Malignancy risk in JAK inhibitors - MACE risk in JAK inhibitors - Oral azoles for head-and-neck dermatitis

Dermasphere - The Dermatology Podcast

Indhold leveret af Luke Johnson. Alt podcastindhold inklusive episoder, grafik og podcastbeskrivelser uploades og leveres direkte af Luke Johnson eller deres podcastplatformspartner. Hvis du mener, at nogen bruger dit ophavsretligt beskyttede værk uden din tilladelse, kan du følge processen beskrevet her https://da.player.fm/legal.

1+ y ago 1:00:36

MP3•Episode hjem

The palm is ~0.5% TBSA -

Insurance companies denying coverage -

Malignancy risk in JAK inhibitors -

MACE risk in JAK inhibitors -

Oral azoles for head-and-neck dermatitis -

Luke's PDPC course and the Intermountain Derm Society meeting: https://registration.socio.events/e/idspdpc23/promo-codes/ATTENDEE

Connect with us!

- Web: https://dermaspherepodcast.com/

- Twitter: @DermaspherePC

- Instagram: dermaspherepodcast

- Facebook: https://www.facebook.com/DermaspherePodcast/

- Check out Luke and Michelle’s other podcast, SkinCast! https://healthcare.utah.edu/dermatology/skincast/

Luke and Michelle report no significant conflicts of interest… BUT check out our friends at:

- Kikoxp.com(a social platform for doctors to share knowledge)

- https://www.levelex.com/games/top-derm (A free dermatology game to learn more dermatology!)

165 episoder

#Fitness #Medicine #Luke Johnson